Previously, we showed that the DNA damage response pathway in the bone marrow of chronic-phase CML patients is activated, possibly due to enforced proliferation signals driven by BCR/ABL1; disruption of the DNA damage response machinery increased susceptibility of CML patients to blast crisis2. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.